FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Data Support Wegovy Positive CV Outcomes

[ Price : $8.95]

Novo Nordisk says data from its landmark Phase 3 SELECT cardiovascular outcomes trial assessing the effects of once-weekly Wegovy ...

FDA Clears InMed.AI NeuroShield Tool

[ Price : $8.95]

FDA clears an InMed.AI 510(k) for NeuroShield, which the company describes as an automated brain geometry-based quantifying analyt...

Exparel Gains Expanded Analgesic Use

[ Price : $8.95]

FDA approves a Pacira BioSciences supplemental NDA to expand Exparels (bupivacaine liposome injectable suspension) label to includ...

Breakthrough Status for Brixton Coolio

[ Price : $8.95]

FDA gives Brixton Biosciences a breakthrough device designation for its Coolio Therapy, which is intended to deliver long-lasting ...

Neurocrine Bio Stops 2 Develoment Programs

[ Price : $8.95]

Based on recent disappointing study data, Neurocrine Biosciences says it is stopping the development of two drugs being evaluated ...

Panel to Mull Multi-Cancer Detection Tests

[ Price : $8.95]

Federal Register notice: FDA announces an 11/29 advisory committee meeting to discuss multi-cancer detection IVDs.

Consent Decree Against Drug Distributor

[ Price : $8.95]

The Puerto Rico federal court enters a consent decree requiring Droguera Betances, one of the territorys largest pharmaceutical di...

Covid Broke Vaccine Reporting System: BMJ

[ Price : $8.95]

A BMJ investigation raises concerns that the federal governments vaccine adverse event system is not operating as planned and safe...

FDA OKs Chikungunya Vaccine

[ Price : $8.95]

FDA approves a Valneva Austria BLA for Ixchiq, a vaccine for preventing chikungunya in individuals aged 18 years and above who are...

BMS Files sBLA for Breyanzi Expanded Use

[ Price : $8.95]

FDA accepts for priority review a Bristol Myers Squibb supplemental BLA for Breyanzi (lisocabtagene maraleucel) to expand its curr...